Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 02 04:00PM ET
26.34
Dollar change
-0.03
Percentage change
-0.10
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Shs Outstand Perf Week2.62%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- Total Holdings34 Perf Month5.84%
Fund Family Bond Type Tagsinnovation Return% 5Y- AUM54.60M Perf Quarter-
Index- Average Maturity Tagshealthcare Return% 10Y NAV% Perf Half Y-
Index Weighting Commodity Type Tagsbiotechnology Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tagsmedical Flows% 1M3.91% 52W Range24.37 - 27.76 Perf YTD5.84%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M3.91% 52W High-5.10% Beta-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD3.91% 52W Low8.10% ATR (14)0.51
Expense0.79% Structure Type Region Flows% 1Y RSI (14)- Volatility0.54% 1.55%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.06 Prev Close26.37
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume4.72K Price26.34
SMA201.41% SMA501.74% SMA2001.74% Trades Volume316 Change-0.10%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.